Statin use in patients with chronic liver disease was associated with a reduced risk of hepatocellular carcinoma (HCC) and ...

Pitavastatin is a novel statin that induces plaque regression and is non-inferior to atorvastatin and, on some measures, superior to simvastatin and to pravastatin in the elderly. Pitavastatin ...

[13] In clinical studies, pitavastatin consistently produces a marked and sustained increase in HDL-C concentrations. Indeed, pitavastatin's ability to elevate HDL-C levels is one factor ...